1
TITLE: Influence of HER2 expression on prognosis in metastatic triple-negative breast cancerdresults from an international, multicenter analysis coordinated by the AGMT Study Group
AUTHORS: Gampenrieder, S. P.; Dezentje, V.; Lambertini, M.; de Nonneville, A.; Marhold, M.; Le Du, F.; Salgado, A. Cortes; Costa, D. Alpuim; Batista, M. Vaz; Ruche, N. Chic; Tinchon, C.; Petzer, A.; Blondeaux, E.; Del Mastro, L.; Targato, G.; Bertucci, F.; Goncalves, A.; Viret, F.; Bartsch, R.; Mannsbart, C.; Deleuze, A.; Robert, L.; Serrano, C. Saavedra; Cortes, M. Gion; Sampaio Alves, M.; Vitorino, M.; Pecen, L.; Singer, C.; Harbeck, N.; Rinnerthaler, G.; Greil, R.; ...More
PUBLISHED: 2023, SOURCE: ESMO OPEN, VOLUME: 8, ISSUE: 1
INDEXED IN: WOS
2
TITLE: Low HER2 expression does not influence prognosis in metastatic triple-negative breast cancer: Results from an international, multicenter analysis coordinated by the Austrian Group Medical Tumor Therapy (AGMT)
AUTHORS: Gampenrieder, S. P.; Dezentje, V.; Lambertini, M.; de Nonneville, A.; Marhold, M.; Le Du, F.; Serrano, C. Saavedra; Costa, D. Alpuim; Blondeaux, E.; Del Mastro, L.; Bertucci, F.; Goncalves, A.; Bartsch, R.; Deleuze, A.; Salgado, A. Cortes; Vitorino, M.; Tinchon, C.; Pecen, L.; Rinnerthaler, G.; Greil, R.;
PUBLISHED: 2022, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 33
INDEXED IN: WOS